Single-Cell Artificial Intelligence for breakthrough biomedical discovery
The company develops artificial intelligence (AI) software for single-cell data analysis. The underlying algorithms allow them to associate patterns in singlecell data with disease status, similar to how state-of-the-art methods for object recognition associate pixel patterns with objects. They provide a software solution (ScaiVision), wrapping their AI technology for R&D customers from academia, pharmaceutical and clinics. Their product makes it possible to analyse single-cell data that has taken weeks to months before, in days. Using deep learning artificial intelligence, ScaiVision greatly increases interpretation depth, analytical complexity and turn-around time.